BRIEF-InDex Pharmaceuticals Q1 EBIT SEK -5.3 Million
Apr 26 (Reuters) - InDex Pharmaceuticals Q1 sales SEK 10.8 million.
- Q1 cash flow from operating activities SEK -33.7 million
- Q1 adjusted EPS SEK -0.01
- Q1 net income SEK -3 million
Apr 26 (Reuters) - InDex Pharmaceuticals Q1 sales SEK 10.8 million.